Repeating pattern of neurons and the chemical structure of cholesterol

The translational potential of cholesterol-based therapies for neurological disease

Tackling cholesterol dyshomeostasis in Huntington disease and age-related pathology.

Announcements

Advertisement

Treatment of multiple sclerosis

The first disease-modifying therapy for relapsing–remitting multiple sclerosis — interferon‑β 1b — was approved by the FDA in 1993. The following 25 years have seen rapid expansion of the therapeutic options as an evolving understanding of the disease has enabled development of therapies with different modes of action.
Milestone

Advertisement

Nature Careers

Jobs

Advertisement